A Study Evaluating the Immunotherapy Treatment for Ovarian Cancer and Other Advanced Malignancies. (clinicaltrials.gov) - Oct 14, 2026 - P1/2 | N=24 | Recruiting | Sponsor: University of Chicago | Not yet recruiting ➔ Recruiting
Enrollment open • Breast Cancer • Lung Cancer • Lung Non-Squamous Non-Small Cell Cancer • Melanoma • Non Small Cell Lung Cancer • Oncology • Ovarian Cancer • Prostate Adenocarcinoma • Prostate Cancer • Refractory Ovarian Cancer • Solid Tumor • ALK • BRAF • CTAG1B • ER • PD-L1 • ROS1
|